Ligand Pharmaceuticals
LGND
#2815
Rank
A$8.72 B
Marketcap
A$436.22
Share price
-2.62%
Change (1 day)
40.66%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2026 (TTM): A$3.86

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$3.85. In 2025 the company made an earnings per share (EPS) of A$9.35 an increase over its 2024 EPS that were of A-$0.07423.

EPS history for Ligand Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$3.86-58.7%
2025A$9.35-12700%
2024A-$0.07423-101.73%
2023A$4.29-245.96%
2022A-$2.94-157.23%
2021A$5.14-2571.43%
2020A-$0.21-100.46%
2019A$45.45353.48%
2018A$10.021025%
2017A$0.89-700%
2016A-$0.15-100.87%
2015A$17.161859.32%
2014A$0.885.36%
2013A$0.838.0704505322479E+18%
2012A$0.0000000000

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.92 157.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.05-72.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.86 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$25.80 571.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$2.09-154.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.47-61.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.71 74.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.27 11.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
A-$0.53-113.90%๐Ÿ‡บ๐Ÿ‡ธ USA